Latest Episodes
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 1 - Targeted therapy
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Multiple Myeloma: Choosing the best treatment regimen in patients with relapsed/refractory MM - Part 2
In this medical education podcast series, myeloma experts Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London,...
HCC: VEGFR-TKI monotherapy for unresectable or advanced HCC in 1st line setting
Prof. Josep Llovet and Prof. Stephen L. Chan discuss a very interesting topic about the use of the VEGFR TKIs monotherapy in the treatment...
Multiple Myeloma: Choosing the best treatment regimen in newly diagnosed patients - Part 1
In this medical education podcast series, myeloma experts Dr. Joshua Richter (Assistant Professor of Medicine and Director of Myeloma at the Tisch Cancer Institute...
HCC: Highlights from ILCA and ESMO 2021
Professor Matthias Pinter, medical hepatologist from the medical University of Vienna in Austria shares some insights from key abstracts and topics discussed at ILCA...
Precision oncology: Diagnosis and treatment of TRK fusion-positive GI cancers
In this podcast, PO CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both...